These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11052307)

  • 1. PYY regulates pancreatic exocrine secretion through multiple receptors in the awake rat.
    Guarita DR; Deng X; Huh YB; Wood PG; Reeve JR; Whitcomb DC
    Dig Dis Sci; 2000 Sep; 45(9):1696-702. PubMed ID: 11052307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X; Guarita DR; Wood PG; Kriess C; Whitcomb DC
    Dig Dis Sci; 2001 Jan; 46(1):156-65. PubMed ID: 11270780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic reevaluation of the binding properties of 125I-[Leu31,Pro34]peptide YY and 125I-peptide YY3-36 to neuropeptide Y receptor subtypes in rat forebrain.
    Gobbi M; Mennini T; Vezzani A
    J Neurochem; 1999 Apr; 72(4):1663-70. PubMed ID: 10098875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracisternal PYY inhibits gastric lesions induced by ethanol in rats: role of PYY-preferring receptors?
    Kawakubo K; Yang H; Taché Y
    Brain Res; 2000 Jan; 854(1-2):30-4. PubMed ID: 10784103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors.
    Grandt D; Siewert J; Sieburg B; al Tai O; Schimiczek M; Goebell H; Layer P; Eysselein VE; Reeve JR; Müller MK
    Pancreas; 1995 Mar; 10(2):180-6. PubMed ID: 7536329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
    Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
    Dumont Y; Jacques D; Bouchard P; Quirion R
    J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors.
    Teyssen S; Grandt D; Niebergall-Roth E; Schimiczek M; Goebell H; Eysselein VE; Reeve JR; Singer MV
    Pancreas; 1996 Jul; 13(1):80-8. PubMed ID: 8783338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antisecretory effect of endogenous forms of peptide YY on fed and fasted rat jejunum.
    Eto B; Boisset M; Anini Y; Voisin T; Desjeux JF
    Peptides; 1997; 18(8):1249-55. PubMed ID: 9396069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
    Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.
    Dumont Y; Fournier A; St-Pierre S; Quirion R
    Synapse; 1996 Feb; 22(2):139-58. PubMed ID: 8787130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
    Goumain M; Voisin T; Lorinet AM; Laburthe M
    Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
    Dumont Y; Cadieux A; Pheng LH; Fournier A; St-Pierre S; Quirion R
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):320-4. PubMed ID: 7854062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats.
    Yang H; Li WP; Reeve JR; Rivier J; Taché Y
    Br J Pharmacol; 1998 Apr; 123(8):1549-54. PubMed ID: 9605560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors.
    Lloyd KC; Grandt D; Aurang K; Eysselein VE; Schimiczek M; Reeve JR
    Am J Physiol; 1996 Jan; 270(1 Pt 1):G123-7. PubMed ID: 8772509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
    Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.